| Dataset | Tahoe Therapeutics Tahoe 100M Perturbation Atlas |
| Category | transcriptomics |
| Type | cell type |
| Description | Clobetasol propionate perturbation in Hs 766T cell line (Tahoe Therapeutics) |
| Similar Terms | |
| Downloads & Tools |
200 genes differentially expressed following the Clobetasol propionate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| AHNAK | AHNAK nucleoprotein | 0.204374 |
| FKBP5 | FK506 binding protein 5 | 0.190244 |
| VCL | vinculin | 0.110272 |
| PHLDB2 | pleckstrin homology-like domain, family B, member 2 | 0.109091 |
| AKAP13 | A kinase (PRKA) anchor protein 13 | 0.108048 |
| EFNA5 | ephrin-A5 | 0.106077 |
| TRIO | trio Rho guanine nucleotide exchange factor | 0.101395 |
| HMGA2 | high mobility group AT-hook 2 | 0.101368 |
| MT2A | metallothionein 2A | 0.0976407 |
| CAPRIN2 | caprin family member 2 | 0.0968678 |
| ESYT2 | extended synaptotagmin-like protein 2 | 0.0920413 |
| ZMYND8 | zinc finger, MYND-type containing 8 | 0.080769 |
| PDLIM5 | PDZ and LIM domain 5 | 0.074217 |
| DOCK5 | dedicator of cytokinesis 5 | 0.0741849 |
| ALCAM | activated leukocyte cell adhesion molecule | 0.0741804 |
| RBM39 | RNA binding motif protein 39 | 0.0735256 |
| MT1X | metallothionein 1X | 0.0696929 |
| MAP4K4 | mitogen-activated protein kinase kinase kinase kinase 4 | 0.0668546 |
| MTSS1 | metastasis suppressor 1 | 0.0636353 |
| KRT6A | keratin 6A, type II | 0.0634115 |
| MCL1 | myeloid cell leukemia 1 | 0.0625185 |
| ABLIM3 | actin binding LIM protein family, member 3 | 0.062499 |
| TXNIP | thioredoxin interacting protein | 0.0616626 |
| YAP1 | Yes-associated protein 1 | 0.0586255 |
| FGD4 | FYVE, RhoGEF and PH domain containing 4 | 0.0577907 |
| TOP1 | topoisomerase (DNA) I | 0.0576317 |
| NIBAN2 | niban apoptosis regulator 2 | 0.0566825 |
| CD55 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | 0.0565504 |
| EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.0560602 |
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.0543107 |
| HIVEP2 | human immunodeficiency virus type I enhancer binding protein 2 | 0.0526986 |
| PALM2AKAP2 | PALM2 and AKAP2 fusion | 0.0523095 |
| IRS2 | insulin receptor substrate 2 | 0.0521528 |
| TBC1D8 | TBC1 domain family, member 8 (with GRAM domain) | 0.0520308 |
| BCL2L1 | BCL2-like 1 | 0.0499766 |
| ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | 0.0497966 |
| RASAL2 | RAS protein activator like 2 | 0.049588 |
| ERRFI1 | ERBB receptor feedback inhibitor 1 | 0.04949 |
| SOD2 | superoxide dismutase 2, mitochondrial | 0.0489438 |
| ZFP36L1 | ZFP36 ring finger protein-like 1 | 0.0462516 |
| NRCAM | neuronal cell adhesion molecule | 0.0456457 |
| UBE2E2 | ubiquitin-conjugating enzyme E2E 2 | 0.0449004 |
| ATP1A4 | ATPase, Na+/K+ transporting, alpha 4 polypeptide | 0.0440611 |
| GLUL | glutamate-ammonia ligase | 0.0440371 |
| CLIC4 | chloride intracellular channel 4 | 0.0439261 |
| PID1 | phosphotyrosine interaction domain containing 1 | 0.0438261 |
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.0437885 |
| FMNL2 | formin-like 2 | 0.0433234 |
| BCAR3 | breast cancer anti-estrogen resistance 3 | 0.0430124 |
| SIPA1L1 | signal-induced proliferation-associated 1 like 1 | 0.0422211 |
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.0419123 |
| RABGAP1L | RAB GTPase activating protein 1-like | 0.0417619 |
| INTS6 | integrator complex subunit 6 | 0.0394233 |
| LMO7 | LIM domain 7 | 0.0392602 |
| ABL2 | ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.0386687 |
| ZFHX3 | zinc finger homeobox 3 | 0.038415 |
| PLXNA2 | plexin A2 | 0.0370934 |
| RTN4 | reticulon 4 | 0.0370062 |
| DGKH | diacylglycerol kinase, eta | 0.0369443 |
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.0365627 |
| ETS1 | v-ets avian erythroblastosis virus E26 oncogene homolog 1 | 0.0365269 |
| ZSWIM6 | zinc finger, SWIM-type containing 6 | 0.0364057 |
| KRT17 | keratin 17, type I | 0.0360952 |
| UTRN | utrophin | 0.0356186 |
| HIPK2 | homeodomain interacting protein kinase 2 | 0.0350182 |
| PSD3 | pleckstrin and Sec7 domain containing 3 | 0.0349844 |
| PLEC | plectin | 0.0347354 |
| FTH1 | ferritin, heavy polypeptide 1 | 0.0343853 |
| JAK1 | Janus kinase 1 | 0.0342043 |
| NAV2 | neuron navigator 2 | 0.0336199 |
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.0330823 |
| DIP2C | DIP2 disco-interacting protein 2 homolog C (Drosophila) | 0.0328918 |
| CLMB | calcimembrin | 0.0327627 |
| CD59 | CD59 molecule, complement regulatory protein | 0.0325223 |
| EZR | ezrin | 0.0324485 |
| LPP | LIM domain containing preferred translocation partner in lipoma | 0.0319675 |
| ASAP2 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 | 0.0318138 |
| OSMR | oncostatin M receptor | 0.0315635 |
| THSD4 | thrombospondin, type I, domain containing 4 | 0.0313923 |
| BIRC3 | baculoviral IAP repeat containing 3 | 0.0311256 |
| SAMD4A | sterile alpha motif domain containing 4A | 0.0309305 |
| SKI | SKI proto-oncogene | 0.0305465 |
| ABLIM2 | actin binding LIM protein family, member 2 | 0.030535 |
| TNS3 | tensin 3 | 0.0304842 |
| STXBP5 | syntaxin binding protein 5 (tomosyn) | 0.0301898 |
| ACSL3 | acyl-CoA synthetase long-chain family member 3 | 0.029907 |
| PTK2 | protein tyrosine kinase 2 | 0.0290069 |
| JPH2 | junctophilin 2 | 0.0288018 |
| LAMB1 | laminin, beta 1 | 0.0286412 |
| SASH1 | SAM and SH3 domain containing 1 | 0.0284826 |
| CDKL5 | cyclin-dependent kinase-like 5 | 0.0283627 |
| SRGAP1 | SLIT-ROBO Rho GTPase activating protein 1 | 0.0283168 |
| TJP1 | tight junction protein 1 | 0.0281509 |
| APBB2 | amyloid beta (A4) precursor protein-binding, family B, member 2 | 0.0279378 |
| NEBL | nebulette | 0.0276837 |
| MICAL2 | microtubule associated monooxygenase, calponin and LIM domain containing 2 | 0.0275742 |
| NCOA3 | nuclear receptor coactivator 3 | 0.0274859 |
| TANC2 | tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 | 0.0274467 |
| CHIC2 | cysteine-rich hydrophobic domain 2 | 0.0270275 |
| ZHX3 | zinc fingers and homeoboxes 3 | 0.026775 |
| Symbol | Name | Standardized Value |
|---|---|---|
| NDRG1 | N-myc downstream regulated 1 | -0.11287 |
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | -0.108863 |
| IL1RAPL1 | interleukin 1 receptor accessory protein-like 1 | -0.0893986 |
| B2M | beta-2-microglobulin | -0.0828514 |
| ITGA6 | integrin, alpha 6 | -0.0801848 |
| CLU | clusterin | -0.078709 |
| CEMIP | cell migration inducing protein, hyaluronan binding | -0.0739545 |
| CD44 | CD44 molecule (Indian blood group) | -0.0709143 |
| MEF2A | myocyte enhancer factor 2A | -0.0708023 |
| SULF1 | sulfatase 1 | -0.0683749 |
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | -0.0615045 |
| KIAA1217 | KIAA1217 | -0.0590887 |
| GPRC5A | G protein-coupled receptor, class C, group 5, member A | -0.0574844 |
| STC1 | stanniocalcin 1 | -0.0548357 |
| NRG1 | neuregulin 1 | -0.0544683 |
| PTMA | prothymosin, alpha | -0.0517529 |
| IFITM3 | interferon induced transmembrane protein 3 | -0.0496414 |
| ADAMTS16 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 | -0.0486833 |
| PODXL | podocalyxin-like | -0.047761 |
| ERC2 | ELKS/RAB6-interacting/CAST family member 2 | -0.045921 |
| GNAS | GNAS complex locus | -0.045701 |
| IFITM1 | interferon induced transmembrane protein 1 | -0.0455036 |
| ASPH | aspartate beta-hydroxylase | -0.0454899 |
| DDX60L | DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like | -0.0448262 |
| LOC112694756 | uncharaterized LOC112694756 | -0.044291 |
| HSPG2 | heparan sulfate proteoglycan 2 | -0.0423124 |
| HLA-B | major histocompatibility complex, class I, B | -0.0415752 |
| NFAT5 | nuclear factor of activated T-cells 5, tonicity-responsive | -0.0408582 |
| PKM | pyruvate kinase, muscle | -0.0402808 |
| TIMP3 | TIMP metallopeptidase inhibitor 3 | -0.0401822 |
| DOK5 | docking protein 5 | -0.0389788 |
| RIN2 | Ras and Rab interactor 2 | -0.0387378 |
| LMNA | lamin A/C | -0.0387365 |
| RPS6 | ribosomal protein S6 | -0.0375016 |
| KTN1 | kinectin 1 (kinesin receptor) | -0.0371534 |
| ENO1 | enolase 1, (alpha) | -0.0368307 |
| MARCKS | myristoylated alanine-rich protein kinase C substrate | -0.0344997 |
| TMSB4X | thymosin beta 4, X-linked | -0.0339103 |
| DSTN | destrin (actin depolymerizing factor) | -0.03368 |
| ST3GAL6 | ST3 beta-galactoside alpha-2,3-sialyltransferase 6 | -0.0327859 |
| IGFBP4 | insulin-like growth factor binding protein 4 | -0.0325694 |
| ALDH3A1 | aldehyde dehydrogenase 3 family, member A1 | -0.0323362 |
| SH3BGRL3 | SH3 domain binding glutamate-rich protein like 3 | -0.0321383 |
| SYNJ2 | synaptojanin 2 | -0.0315507 |
| LIMA1 | LIM domain and actin binding 1 | -0.0313936 |
| NUCKS1 | nuclear casein kinase and cyclin-dependent kinase substrate 1 | -0.0313799 |
| PLAT | plasminogen activator, tissue | -0.0312054 |
| ARL6IP1 | ADP-ribosylation factor-like 6 interacting protein 1 | -0.0298982 |
| HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 | -0.0290026 |
| PPFIBP1 | PTPRF interacting protein, binding protein 1 (liprin beta 1) | -0.0285942 |
| CAMK2D | calcium/calmodulin-dependent protein kinase II delta | -0.0285527 |
| PFN1 | profilin 1 | -0.0281773 |
| LNPEP | leucyl/cystinyl aminopeptidase | -0.0281366 |
| MAML2 | mastermind-like 2 (Drosophila) | -0.0280805 |
| MRPS6 | mitochondrial ribosomal protein S6 | -0.027885 |
| KMT2E | lysine (K)-specific methyltransferase 2E | -0.0278797 |
| FRMD5 | FERM domain containing 5 | -0.0277734 |
| BHLHE40 | basic helix-loop-helix family, member e40 | -0.0276135 |
| EPHA2 | EPH receptor A2 | -0.0273303 |
| MBNL2 | muscleblind-like splicing regulator 2 | -0.027324 |
| FTL | ferritin, light polypeptide | -0.0271956 |
| SULF2 | sulfatase 2 | -0.026595 |
| UACA | uveal autoantigen with coiled-coil domains and ankyrin repeats | -0.0265273 |
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | -0.0263941 |
| EPB41L1 | erythrocyte membrane protein band 4.1-like 1 | -0.0261584 |
| SLC35F3 | solute carrier family 35, member F3 | -0.0261444 |
| EHF | ets homologous factor | -0.0260183 |
| RPS19 | ribosomal protein S19 | -0.025772 |
| IFI16 | interferon, gamma-inducible protein 16 | -0.0256871 |
| ERO1A | endoplasmic reticulum oxidoreductase 1 alpha | -0.0252623 |
| DHRS3 | dehydrogenase/reductase (SDR family) member 3 | -0.0250824 |
| S100A6 | S100 calcium binding protein A6 | -0.0250685 |
| DLG1 | discs, large homolog 1 (Drosophila) | -0.0247167 |
| RPLP2 | ribosomal protein, large, P2 | -0.024465 |
| CNRIP1 | cannabinoid receptor interacting protein 1 | -0.0238006 |
| GRB10 | growth factor receptor-bound protein 10 | -0.0237309 |
| PPDPF | pancreatic progenitor cell differentiation and proliferation factor | -0.0237302 |
| GATA6 | GATA binding protein 6 | -0.023696 |
| SOX7 | SRY (sex determining region Y)-box 7 | -0.0236181 |
| AKAP9 | A kinase (PRKA) anchor protein 9 | -0.0231873 |
| ARRDC3 | arrestin domain containing 3 | -0.0229458 |
| EXT1 | exostosin glycosyltransferase 1 | -0.0226871 |
| CMIP | c-Maf inducing protein | -0.0226812 |
| MDK | midkine (neurite growth-promoting factor 2) | -0.0226293 |
| SAMD9 | sterile alpha motif domain containing 9 | -0.0224982 |
| FSCN1 | fascin actin-bundling protein 1 | -0.0224647 |
| TOP2A | topoisomerase (DNA) II alpha 170kDa | -0.0223459 |
| FOSL1 | FOS-like antigen 1 | -0.0222452 |
| DST | dystonin | -0.0222145 |
| RALGDS | ral guanine nucleotide dissociation stimulator | -0.0221773 |
| IFI6 | interferon, alpha-inducible protein 6 | -0.0221116 |
| POTEF | POTE ankyrin domain family, member F | -0.0219481 |
| PTP4A2 | protein tyrosine phosphatase type IVA, member 2 | -0.0219312 |
| RPLP1 | ribosomal protein, large, P1 | -0.0218893 |
| SH3PXD2A | SH3 and PX domains 2A | -0.0218549 |
| IFIT2 | interferon-induced protein with tetratricopeptide repeats 2 | -0.0218363 |
| NHS | Nance-Horan syndrome (congenital cataracts and dental anomalies) | -0.0218014 |
| RPL32 | ribosomal protein L32 | -0.0217402 |
| IGF2 | insulin-like growth factor 2 | -0.021724 |
| TAGLN2 | transgelin 2 | -0.0216863 |
